期刊文献+

COPD患者血脂代谢水平和hs-CRP水平关系的分析 被引量:3

Analysis of Relationship Between Blood Lipid Metabolism Levels and hs-CRP Levels in Patients with Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:进行慢性阻塞性肺病(COPD)患者血脂代谢水平和hs-CRP水平关系的分析。方法:利用生化法测定了96例COPD患者血脂代谢水平,免疫比浊法测定了血清hs-CRP水平,并与68例正常对照组进行了比较。结果:96例COPD患者的血浆TC、TG、HDL-C、LDL-C和Lp(a)较之68例正常对照组明显降低,TC和LDL-C水平无明显差异(P>0.05),HDL-C水平具有明显差异(P<0.05),而TG和Lp(a)水平具有非常明显的差异(P<0.01)。血浆hs-CRP水平明显升高,具有非常明显的差异(P<0.01),并且COPD患者中的血脂代谢水平和hs-CRP水平存在着直接的相关性。结论:COPD患者血脂水平和hs-CRP水平相关性的分析,有助于了解其发病机制。 Objective To study the relationship between blood lipid metabolism levels and hs-CRP levels in the patients with chronic obstructive pulmonary disease.Methods The levels of plasma blood lipid(with biochemistry) and serum hs-CRP(with high-sensitive immunoturbidimetry) were determined in 96 patients with chronic obstructive pulmonary disease as well as 68 normal controls.Results The plasma blood lipid levels in 96 patients with chronic obstructive pulmonary disease were significantly lower than those in 68 controls,plasma TC and LDL-C levels were not much difference(P0.05),plasma HDL-C level was significantly difference(P0.05),but TG and Lp(a) levels were very prominently difference(P0.01).And the plasma hs-CRP level was significantly increased also(P0.01).The close relationship was between blood lipid and hs-CRP levels.Conclusion The study of relationship between blood lipid levels and hs-CRP levels in patients with COPD was helpful for understend the disease process as well as possible mechanisms.
作者 尤凤坚
出处 《放射免疫学杂志》 CAS 2011年第2期185-187,共3页 Journal of Radioimmanology
关键词 慢性阻塞性肺病(COPD) 血脂 超敏C-反应蛋白(hs-CRP) chronic obstructive pulmonary disease(COPD) blood lipid high sensitive C-reactive protein(hs-CRP)
  • 相关文献

参考文献13

  • 1Rabe KF,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):527-535.
  • 2Calabro P,Chang DW,Wilerson JT,et al.Release of C-reactive protein in response to inflammatory cytokines by human adipocytes:Linking obesity to vascular inflammation[J].Am coll Cardiol,2005,46(6):1112-1113.
  • 3朱文珏,陈文斌.呼吸病学[M].第1版.北京:人民卫生出版社,2002,333.
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 5赵华昌,李晓萍,张倩.慢性阻塞性肺疾病与血脂关系的临床探讨[J].现代预防医学,2007,34(6):1194-1195. 被引量:11
  • 6刘韵蝉,赵兰,梅元英.慢性阻塞性肺疾病患者脂质代谢研究[J].贵阳医学院学报,2001,26(1):34-35. 被引量:8
  • 7Emtner M,Hsdin A,Andersson M,et al.Impact of patients characteristics,education and knowledge on emergency room visits in patients with asthma and COPD:a descriptive and correlative study[J].BMC Pulm Med,2009,9:43-49.
  • 8Niewoehner DE.The impact of the severe exacerbations on quality of life and clinical course of chronic obstrutive pulmonary disease[J].Am J Med,2006,119(10 suppl 1):38-45.
  • 9Vaisar T,Pennathur S,Green S,et al.Shotgun proteomics implicates protease inhibition and complement activation in the anti inflammatory properties of HDL[J].J Clin Invest,2007,117(3):746-756.
  • 10Restriepo RD,Alvarer MT,Wittnebel LD,et al.Medication adherence issues in patients treated for COPD[J].Int J Chron Pulmon Dis,2008,3(3):371-384.

二级参考文献17

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2陈灏珠.实用内科学[M].北京:人民卫生出版社,2002.1843.
  • 3汪丽慧主编.今日内科呼吸疾病分册[M].北京:北京医科大学,中国协和医科大学联合出版社,1992.17-21.
  • 4吴满平.载脂蛋白基因与功能研究[J].生理学进展,1988,19:135-135.
  • 5Rohcim P S. Athcrosclcrosis and lipoprotcin mctabolism. Role of reverse chloesteroltransport [J].Am J Cardiol, 1988,57:30.
  • 6GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 7Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 8Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 9冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 10Lacoobs D.Report of the conference on low blood cholesterol mortality association circulation[J].1982,86:1046.

共引文献8241

同被引文献43

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5222
  • 3Amaud C,Dematteis M,Pepin JL,et al.Obstructive sleep apnea,immuno-inflammation,and atherosc1erosis[J].Semin Immunopathol,2009,31(1):113-125.
  • 4Shahar E,Whitney CW,Redline S,et al.Sleep-disordered breathing and cardiovascular disease:cross-sectional results of the Sleep Heart Health Study[J].Am J Respir Crit Care Med,2001,163(1):19-25.
  • 5Conte G,Rigon N,Perrone A,et al.Acute cardiovascular disease and respiratory sleep disorders[J].Minerva Cardioangiol,1999,47(6):195-202.
  • 6Lavie P,Herer P,Hoffstein V.Obstructive sleep apnea syndrome as a risk factor for hypertension:population study[J].BMJ,2000,320(7233):479-482.
  • 7Peppard PE,Young T,Palta M.Prospective study of the association between sleep-disordered breathing and hypertension[J].N Eng J Med,2000,342(19):1378-1384.
  • 8Coughlin SR,Mawdsley L,Mugarza JA,et al.Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome[J].Eur Heart J,2004,25(9):735-741.
  • 9Li J,Savransky V,Nanayakkara A,et al.Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia[J].J Appl Physiol,2007,102(2):557-563.
  • 10Choy PC,SiowYL,Mymin D,et al.Lipids and atherosclerosis[J].Biochem Cell Biol,2004,82(1):212-224.

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部